Miyoung Chun’s career spans a wide range of experience in academia, industry, and philanthropy. She was a Professor of Biochemistry at Boston University School of Medicine, where she taught and performed research in the areas of cell biology and molecular medicine. As a scientist and project leader at Millennium Pharmaceuticals Inc. (now The Takeda Oncology Company), her research focused on functional genomics and molecular imaging in drug discovery and development, leading to over 30 U.S. and internationally issued/published patents. As the Executive Vice President of Science Programs at The Kavli Foundation, Dr. Chun has spearheaded many scientific initiatives and dynamic large-scale projects, including the development and launch of the BRAIN Initiative. Announced in 2013 by President Obama as the White House’s centerpiece Grand Challenge, BRAIN represents scientific collaboration in its truest form, marshaling private and public sectors and scientists from across disciplines to work together in order to accelerate innovative technologies that will revolutionize our understanding of the brain.